Lamisil 125 mg
Lamisil 125 mg is a medicine authorised by Swissmedic under authorisation number 51306. The authorisation holder is Novartis Pharma Schweiz AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 27 August 1991 and the authorisation is valid without a time limit. ATC code D01BA02 places the medicine in the group Antifungals for dermatological use.
| Authorisation number | 51306 |
|---|---|
| Name | Lamisil 125 mg |
| Full name | Lamisil 125 mg, Tabletten |
| Authorisation holder | Novartis Pharma Schweiz AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | D01BA02 |
| First authorisation | 27 August 1991 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Lamisil 125 mg, Tabletten | B | 27 August 1991 |
| 2 | Lamisil 250 mg, Tabletten | B | 27 August 1991 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 31 | 14 | Tablette(n) | D01BA02 | 08.06.0. | B |
| 15 | 14 | Tablette(n) | D01BA02 | 08.06.0. | B |
| 23 | 28 | Tablette(n) | D01BA02 | 08.06.0. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Lamisil 125 mg authorised in Switzerland?
Yes. Lamisil 125 mg is authorised by Swissmedic under authorisation number 51306, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Lamisil 125 mg have?
Lamisil 125 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Lamisil 125 mg?
The authorisation holder is Novartis Pharma Schweiz AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.